Literature DB >> 11084572

Regular disappearance of the human papillomavirus genome after conization of cervical dysplasia by carbon dioxide laser.

L Kjellberg1, G Wadell, F Bergman, M Isaksson, T Angström, J Dillner.   

Abstract

OBJECTIVE: We wished to evaluate the effectiveness of treatment of cervical dysplasia by laser conization in relation to persistence of human papillomavirus after treatment. STUDY
DESIGN: Of 203 women referred to colposcopy because of an abnormal Papanicolaou smear, 149 women could be followed up for 3 years. A total of 108 women were treated by carbon dioxide laser excision, 4 women were treated by carbon dioxide laser evaporation, and 37 women were merely followed up. Cervical samples were taken before treatment and at follow-up 3 years later and were analyzed by nested general primer polymerase chain reaction for human papillomavirus deoxyribonucleic acid.
RESULTS: Among women treated by laser conization, 82 (73.2%) had positive results for human papillomavirus deoxyribonucleic acid before treatment. Three women (2.7%) had a positive finding at follow-up, but no woman had the same human papillomavirus type on both occasions. Eighty-eight women had grade 1 to grade 3 cervical intraepithelial neoplasia before treatment, whereas during follow-up only 2 squamous cells atypias were found.
CONCLUSION: The human papillomavirus genome present before treatment was regularly cleared, and there was also no recurrence of dysplasia. The results suggest that human papillomavirus testing is useful for monitoring the efficacy of treatment and that treatment modalities resulting in clearance of human papillomavirus should be favored.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11084572     DOI: 10.1067/mob.2000.107322

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

Review 1.  The incidence of human papillomavirus infection following treatment for cervical neoplasia: a systematic review.

Authors:  Anne F Rositch; Heidi M Soeters; Tabatha N Offutt-Powell; Bradford S Wheeler; Sylvia M Taylor; Jennifer S Smith
Journal:  Gynecol Oncol       Date:  2014-01-07       Impact factor: 5.482

2.  Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment.

Authors:  Aimée R Kreimer; Mark Schiffman; Rolando Herrero; Allan Hildesheim; Paula González; Robert D Burk; Carolina Porras; Mark E Sherman; Franklin Demuth; Li Cheung; Concepción Bratti; Ana Cecilia Rodríguez
Journal:  Int J Cancer       Date:  2011-08-30       Impact factor: 7.396

3.  Does HPV-status 6-12 months after treatment of high grade dysplasia in the uterine cervix predict long term recurrence?

Authors:  Björn Strander; Walter Ryd; Keng-Ling Wallin; Bengt Wärleby; Biying Zheng; Ian Milsom; Baback Gharizadeh; Nader Pourmand; Agneta Andersson-Ellström
Journal:  Eur J Cancer       Date:  2007-07-05       Impact factor: 9.162

4.  Human papillomavirus Posttreatment Clearance Time in Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer.

Authors:  Guligeina Abudurexiti; Gulixian Tuerxun; Guzhalinuer Abulizi; Patiman Mijiti; Kailibinuer Aierken; Anaerguli Maimaiti; Hua Li
Journal:  J Low Genit Tract Dis       Date:  2020-01       Impact factor: 3.842

5.  Frequency of L-SIL and H-SIL Findings in HPV Positive Women.

Authors:  Amir Asotic; Suada Taric; Jasminka Asotic
Journal:  Mater Sociomed       Date:  2014-04-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.